An expanded role for neuroimaging in the evaluation of memory impairment
Alzheimer disease affects millions of people worldwide. The neuropathologic process
underlying this disease begins years, if not decades, before the onset of memory decline …
underlying this disease begins years, if not decades, before the onset of memory decline …
Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease
GW Small - Journal of geriatric psychiatry and neurology, 2006 - journals.sagepub.com
Structural neuroimaging is a routine component of the diagnostic evaluation of dementia that
is used to rule out potential causes of mental impairment, whereas functional imaging can …
is used to rule out potential causes of mental impairment, whereas functional imaging can …
Empowering imaging biomarkers of Alzheimer's disease
In a previous report, we proposed a method for combining multiple markers of atrophy
caused by Alzheimer's disease into a single atrophy score that is more powerful than any …
caused by Alzheimer's disease into a single atrophy score that is more powerful than any …
Neuroimaging in Alzheimer disease: an evidence-based review
K Kantarci, CR Jack - Neuroimaging Clinics, 2003 - neuroimaging.theclinics.com
Alzheimer disease (AD) is the most common dementing illness. The prevalence of AD
increases with age, and the disease is becoming a significant health problem as the aging …
increases with age, and the disease is becoming a significant health problem as the aging …
What does imaging add to the management of Alzheimer's disease?
GW Small - CNS spectrums, 2004 - cambridge.org
The prevalence of Alzheimer's disease (AD) and dementia continues to rise. However, a
significant number of patients are undiagnosed or untreated. Given the complexities of …
significant number of patients are undiagnosed or untreated. Given the complexities of …
Early diagnosis of Alzheimer's disease and mild cognitive impairment: Imaging, biomarkers, and technology
T Buracchio, J Kaye - Generations, 2009 - ingentaconnect.com
The neuropathological changes of Alzheimer's most likely begin years before a clinical
diagnosis of dementia or even mild cognitive impairment. As potential disease-modifying …
diagnosis of dementia or even mild cognitive impairment. As potential disease-modifying …
Advances in imaging of AD biomarkers could aid early diagnosis
A Chase - Nature Reviews Neurology, 2014 - go.gale.com
The neuropathological effects of Alzheimer disease (AD) can be clearly observed at
autopsy, but identifying diagnostic and prognostic biomarkers in living people is less …
autopsy, but identifying diagnostic and prognostic biomarkers in living people is less …
Neuroimaging in dementias
The combined use of neuroimaging examinations with clinical, neuropsychological, and
cerebrospinal fluid markers can improve the specificity of the diagnosis of Alzheimer's …
cerebrospinal fluid markers can improve the specificity of the diagnosis of Alzheimer's …
In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease
J Cui, V Zufferey, F Kherif - Current opinion in neurology, 2015 - journals.lww.com
The discovery of efficient therapies to prevent the disease or modify the progression of
disease requires a more thorough understanding of the underlying biological processes …
disease requires a more thorough understanding of the underlying biological processes …
[PDF][PDF] Neuroimaging in dementia: a brief review
D Banerjee, A Muralidharan, ARH Mohammed… - Cureus, 2020 - cureus.com
Dementia is a clinical syndrome that manifests itself with impairment in cognitive functions
owing to various neurodegenerative etiologies causing severe disability in the older …
owing to various neurodegenerative etiologies causing severe disability in the older …